under way, pfizer s ceo says he expects the omicron variant vaccine to be ready quickly, in march, which is, after all, only a few weeks away. even before we ve got an omicron variant specific vaccine, though, lots of u.s. states hit hardest in the early part of the omicron variant wave are already seeing cases decline rapidly, because we re seeing that in multiple hard-hit state, even while the variant continues to surge in states with low vaccination rate, our overall national case count is also now starting to drop. we appear to be on the downward side of the curve in terms of the omicron crush. dr. ashish aja, the dean of brown public school of public health. put it this way in the washington post, the head line as you can see it, the worst of omicron might have passed, but the pandemic is not over. dr. aja suggested that we use the next few months when we see the lower level of virus to get ready for the next surge or next
and it s important that we look across the whole to make sure transplants are successful when available. these policies are put in place to best prepare patients to have successful transplants. doctor, i want you to help us understand, how should we read these new pfizer trials, clinical trials for a new omicron variant vaccine. let s say they come out with the vaccine a few months from now. why do we need a specific one for this variant, and what does that mean if we have been vaccinated and have the booster, how does this vaccine help? the most important thing to take away is this is incredible good news. when we think about the two years it took us to be able to generate this robust vaccine that s available and around for everyone to take against covid, the ability of our vaccine companies, like pfizer, to now produce very quickly a variant-specific vaccine speaks to the amazing advances in the technology. but do we need to take it. well, we will see.